Extending OmpSs for OpenCL kernel co-execution in heterogeneous systems

© 2017 IEEE. Personal use of this material is permitted. Permission from IEEE must be obtained for all other uses, in any current or future media, including reprinting/republishing this material for advertising or promotional purposes,creating new collective works, for resale or redistribution to servers or lists, or reuse of any copyrighted component of this work in other works.Heterogeneous systems have a very high potential performance but present difficulties in their programming. OmpSs is a well known framework for task based parallel applications, which is an interesting tool to simplify the programming of these systems. However, it does not support the co-execution of a single OpenCL kernel instance on several compute devices. To overcome this limitation, this paper presents an extension of the OmpSs framework that solves two main objectives: the automatic division of datasets among several devices and the management of their memory address spaces. To adapt to different kinds of applications, the data division can be performed by the novel HGuided load balancing algorithm or by the well known Static and Dynamic. All this is accomplished with negligible impact on the programming. Experimental results reveal that there is always one load balancing algorithm that improves the performance and energy consumption of the system.This work has been supported by the University of Cantabria with grant CVE-2014-18166, the Generalitat de Catalunya under grant 2014-SGR-1051, the Spanish Ministry of Economy, Industry and Competitiveness under contracts TIN2016- 76635-C2-2-R (AEI/FEDER, UE) and TIN2015-65316-P. The Spanish Government through the Programa Severo Ochoa (SEV-2015-0493). The European Research Council under grant agreement No 321253 European Community’s Seventh Framework Programme [FP7/2007-2013] and Horizon 2020 under the Mont-Blanc Projects, grant agreement n 288777, 610402 and 671697 and the European HiPEAC Network.Peer ReviewedPostprint (published version

Lenalidomide and dexamethasone with or without clarithromycin in patients with multiple myeloma ineligible for autologous transplant: a randomized trial

Although case-control analyses have suggested an additive value with the association of clarithromycin to continuous lenalidomide and dexamethasone (Rd), there are not phase III trials confirming these results. In this phase III trial, 286 patients with MM ineligible for ASCT received Rd with or without clarithromycin until disease progression or unacceptable toxicity. The primary endpoint was progression-free survival (PFS). With a median follow-up of 19 months (range, 0-54), no significant differences in the median PFS were observed between the two arms (C-Rd 23 months, Rd 29 months; HR 0.783, p = 0.14), despite a higher rate of complete response (CR) or better in the C-Rd group (22.6% vs 14.4%, p = 0.048). The most common G3-4 adverse events were neutropenia [12% vs 19%] and infections [30% vs 25%], similar between the two arms; however, the percentage of toxic deaths was higher in the C-Rd group (36/50 [72%] vs 22/40 [55%], p = 0.09). The addition of clarithromycin to Rd in untreated transplant ineligible MM patients does not improve PFS despite increasing the ?CR rate due to the higher number of toxic deaths in the C-Rd arm. Side effects related to overexposure to steroids due to its delayed clearance induced by clarithromycin in this elderly population could explain these results. The trial was registered in clinicaltrials.gov with the name GEM-CLARIDEX: Ld vs BiRd and with the following identifier NCT02575144. The full trial protocol can be accessed from ClinicalTrials.gov. This study received financial support from BMS/Celgene

RICORS2040 : The need for collaborative research in chronic kidney disease

Chronic kidney disease (CKD) is a silent and poorly known killer. The current concept of CKD is relatively young and uptake by the public, physicians and health authorities is not widespread. Physicians still confuse CKD with chronic kidney insufficiency or failure. For the wider public and health authorities, CKD evokes kidney replacement therapy (KRT). In Spain, the prevalence of KRT is 0.13%. Thus health authorities may consider CKD a non-issue: very few persons eventually need KRT and, for those in whom kidneys fail, the problem is 'solved' by dialysis or kidney transplantation. However, KRT is the tip of the iceberg in the burden of CKD. The main burden of CKD is accelerated ageing and premature death. The cut-off points for kidney function and kidney damage indexes that define CKD also mark an increased risk for all-cause premature death. CKD is the most prevalent risk factor for lethal coronavirus disease 2019 (COVID-19) and the factor that most increases the risk of death in COVID-19, after old age. Men and women undergoing KRT still have an annual mortality that is 10- to 100-fold higher than similar-age peers, and life expectancy is shortened by ~40 years for young persons on dialysis and by 15 years for young persons with a functioning kidney graft. CKD is expected to become the fifth greatest global cause of death by 2040 and the second greatest cause of death in Spain before the end of the century, a time when one in four Spaniards will have CKD. However, by 2022, CKD will become the only top-15 global predicted cause of death that is not supported by a dedicated well-funded Centres for Biomedical Research (CIBER) network structure in Spain. Realizing the underestimation of the CKD burden of disease by health authorities, the Decade of the Kidney initiative for 2020-2030 was launched by the American Association of Kidney Patients and the European Kidney Health Alliance. Leading Spanish kidney researchers grouped in the kidney collaborative research network Red de Investigación Renal have now applied for the Redes de Investigación Cooperativa Orientadas a Resultados en Salud (RICORS) call for collaborative research in Spain with the support of the Spanish Society of Nephrology, Federación Nacional de Asociaciones para la Lucha Contra las Enfermedades del Riñón and ONT: RICORS2040 aims to prevent the dire predictions for the global 2040 burden of CKD from becoming true

Identification of Novel Genetic Markers Associated with Clinical Phenotypes of Systemic Sclerosis through a Genome-Wide Association Strategy

Contains fulltext : 97006.pdf (publisher's version ) (Open Access)The aim of this study was to determine, through a genome-wide association study (GWAS), the genetic components contributing to different clinical sub-phenotypes of systemic sclerosis (SSc). We considered limited (lcSSc) and diffuse (dcSSc) cutaneous involvement, and the relationships with presence of the SSc-specific auto-antibodies, anti-centromere (ACA), and anti-topoisomerase I (ATA). Four GWAS cohorts, comprising 2,296 SSc patients and 5,171 healthy controls, were meta-analyzed looking for associations in the selected subgroups. Eighteen polymorphisms were further tested in nine independent cohorts comprising an additional 3,175 SSc patients and 4,971 controls. Conditional analysis for associated SNPs in the HLA region was performed to explore their independent association in antibody subgroups. Overall analysis showed that non-HLA polymorphism rs11642873 in IRF8 gene to be associated at GWAS level with lcSSc (P = 2.32x10(-12), OR = 0.75). Also, rs12540874 in GRB10 gene (P = 1.27 x 10(-6), OR = 1.15) and rs11047102 in SOX5 gene (P = 1.39x10(-7), OR = 1.36) showed a suggestive association with lcSSc and ACA subgroups respectively. In the HLA region, we observed highly associated allelic combinations in the HLA-DQB1 locus with ACA (P = 1.79x10(-61), OR = 2.48), in the HLA-DPA1/B1 loci with ATA (P = 4.57x10(-76), OR = 8.84), and in NOTCH4 with ACA P = 8.84x10(-21), OR = 0.55) and ATA (P = 1.14x10(-8), OR = 0.54). We have identified three new non-HLA genes (IRF8, GRB10, and SOX5) associated with SSc clinical and auto-antibody subgroups. Within the HLA region, HLA-DQB1, HLA-DPA1/B1, and NOTCH4 associations with SSc are likely confined to specific auto-antibodies. These data emphasize the differential genetic components of subphenotypes of SSc

Extending OmpSs for OpenCL kernel co-execution in heterogeneous systems

© 2017 IEEE. Personal use of this material is permitted. Permission from IEEE must be obtained for all other uses, in any current or future media, including reprinting/republishing this material for advertising or promotional purposes,creating new collective works, for resale or redistribution to servers or lists, or reuse of any copyrighted component of this work in other works.Heterogeneous systems have a very high potential performance but present difficulties in their programming. OmpSs is a well known framework for task based parallel applications, which is an interesting tool to simplify the programming of these systems. However, it does not support the co-execution of a single OpenCL kernel instance on several compute devices. To overcome this limitation, this paper presents an extension of the OmpSs framework that solves two main objectives: the automatic division of datasets among several devices and the management of their memory address spaces. To adapt to different kinds of applications, the data division can be performed by the novel HGuided load balancing algorithm or by the well known Static and Dynamic. All this is accomplished with negligible impact on the programming. Experimental results reveal that there is always one load balancing algorithm that improves the performance and energy consumption of the system.This work has been supported by the University of Cantabria with grant CVE-2014-18166, the Generalitat de Catalunya under grant 2014-SGR-1051, the Spanish Ministry of Economy, Industry and Competitiveness under contracts TIN2016- 76635-C2-2-R (AEI/FEDER, UE) and TIN2015-65316-P. The Spanish Government through the Programa Severo Ochoa (SEV-2015-0493). The European Research Council under grant agreement No 321253 European Community’s Seventh Framework Programme [FP7/2007-2013] and Horizon 2020 under the Mont-Blanc Projects, grant agreement n 288777, 610402 and 671697 and the European HiPEAC Network.Peer Reviewe

Characterizing the high breast cancer incidence in Bacolod City, Philippines

This paper characterizes the high incidence of breast cancer in Bacolod City, Philippines. The methods of research involved (1) an epidemiological study; (2) a determination study on the environmental factors that cause breast cancer; and (3) a breast cancer behavioral study. A statistical analysis of the personal demography profile found significant indicators of the presence or absence of breast cancer in the areas of breastfeeding duration (p = 0.0029), age when they experienced first sexual intercourse (p = 0.0449), cancer cases in the family (p \u3c 0.0001), incidence of smoking (p = 0.0322), and occupation (p \u3c 0.0001). From an environmental perspective, data obtained from the Department of Environment and Natural Resources (DENR) Region 6 showed nothing of suspect. The sociological dimension found a correlation between stress and the presence or vulnerability of patients and their families to breast cancer incidences. The study likewise found that the women in the study incorporated a range of attitude and behavior that directly and indirectly aim to manage the strains of home and office works revolving around the confluence of (i) faith, (ii) their family, and (iii) and anticipated future. The study promotes the creation of breast cancer support groups as they present a positive and viable mechanism within the community to create social awareness about breast cancer and foster genuine social support networks for its members and their families as well as promote initiatives for low-income members to obtain medicines, referrals, and information. Investing in counseling for the survivors and their families leads to stress management and increased awareness about self-examination, increasing the probability of early detection. Overall, this study can serve as an important document that could be used by government agencies in drawing up screening as well as treatment and management programs for breast cancer in the Philippines. © 2019 by De La Salle University